- Quipt (QIPT) has received conditional approval to graduate its listing from the TSX Venture Exchange to the TSX
- Final approval of the listing is subject to certain conditions required by the TSX, which the company said it is working toward satisfying
- Upon satisfaction of the TSX listing conditions, Quipt’s common shares will be delisted from the TSXV
- Quipt Home Medical (QIPT) opened trading at $8.18 per share
Quipt (QIPT) has received conditional approval to graduate its listing from the TSX Venture Exchange to the TSX.
Final approval of the listing is subject to certain conditions required by the TSX, which the company said it is working toward satisfying.
Quipt’s Chairman and CEO, Greg Crawford explained that up-listing demonstrates the company’s evolution through the years and the ongoing momentum across the business in real time as the team strives to become a national leader in respiratory care.
“This up-listing is an important step towards improving liquidity and increasing our investor audience in North America and abroad,” he said. “Given the continued financial and operational success, this up-listing, and our effort to inform investors of our robust growth, have us extremely optimistic about the future.”
The company intends to release more details and a timeline for its graduation at a later date. Upon satisfaction of the TSX listing conditions, Quipt’s common shares will be delisted from the TSXV.
Quipt Home Medical is a U.S.-based home medical equipment provider focused on end-to-end respiratory care.
Quipt Home Medical (QIPT) opened trading at $8.18 per share.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
